can imuran cause elevated liver enzymes?
602990
Azathioprine is associated with minor, usually transient and asymptomatic elevations in serum aminotransferase levels during therapy and with rare instances of acute, cholestatic liver injury and, with long term use, noncirrhotic portal hypertension as a result of nodular regenerative hyperplasia or sinusoidal ...
1373722
Hepatotoxicity. Chronic use of kratom recreationally has been associated with rare instances of acute liver injury. The onset of injury is usually within 1 to 8 weeks of starting regular use of kratom powder or tablets, with symptoms of fatigue, nausea, pruritus and dark urine followed by jaundice.
1065123
Aspirin, ibuprofen, and naproxen sodium can cause toxic liver disease if you take too much of the drug or take it with alcohol.
118250
OTC pain relievers: Acetaminophen. Nonsteroidal anti-inflammatory drugs (NSAIDs) Aspirin, ibuprofen, and naproxen sodium can cause toxic liver disease if you take too much of the drug or take it with alcohol.
850287
Medical conditions such as hepatitis (swelling of the liver), nonalcoholic fatty liver disease, the metabolic syndrome, and alcoholic liver disease are the more common causes. Certain medicines can also cause elevated liver enzymes.
486320
Cholestasis During Pregnancy Other possible etiologies of mild or moderate elevations of ALT are drug-induced hepatotoxicity, hyperemesis gravidarum, cholelithiasis, HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome or acute fatty liver of pregnancy.
264627
Tysabri May Cause Liver Damage, Health Officials Say. WEDNESDAY, Feb. 27 (HealthDay News) -- The controversial multiple sclerosis drug Tysabri can start causing liver damage within six days of the first dose, U.S. health officials said Wednesday.
1356231
Meprate 10mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
991386
Other possible etiologies of mild or moderate elevations of ALT are drug-induced hepatotoxicity, hyperemesis gravidarum, cholelithiasis, HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome or acute fatty liver of pregnancy.
912106
High ALP usually means that either the liver has been damaged or a condition causing increased bone cell activity is present. If other liver tests such as bilirubin, aspartate aminotransferase (AST), or alanine aminotransferase (ALT) are also high, usually the increased ALP is caused by liver damage or disease.
895482
Ruxolitinib is associated with transient and usually mild elevations in serum aminotransferase during therapy, but has not been linked to cases of clinically apparent idiosyncratic acute liver injury but has been shown to be a cause of reactivation of hepatitis B.
304018
High doses of levothyroxine and other thyroid preparations, however, can cause serum enzyme elevations, typically in a hepatocellular or mixed pattern. Indeed, spontaneous hyperthyroidism can be accompanied by serum enzyme elevations and even jaundice.
1050815
Acetaminophen. Nonsteroidal anti-inflammatory drugs (NSAIDs) Aspirin, ibuprofen, and naproxen sodium can cause toxic liver disease if you take too much of the drug or take it with alcohol.
1431917
Coumarin is a chemical compound found in several plants, including cinnamon, that can cause liver damage in large doses. However, coumarin is not present in Ceylon cinnamon, which means it has the wonderful benefits of cinnamon without this drawback.
1061370
Hepatotoxicity. Alprazolam, like other benzodiazepines, is rarely associated with serum ALT elevations, and clinically apparent liver injury from alprazolam is extremely rare. There have been a few case reports of acute liver injury from alprazolam and recurrence on reexposure has been reported.
864383
High levels of ALT may indicate liver damage from hepatitis, infection, cirrhosis, liver cancer, or other liver diseases. Other factors, including medicines, can affect your results.
281777
Potential hepatic injuries, such as elevated hepatic enzyme levels have been reported for duloxetine in pre-marketing clinical trials and in the post-marketing period [6], but these reports have, in some cases, been associated with excessive alcohol use or pre-existing liver disease.